# OnCo record nct05563844 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05563844/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05563844", "NCT05563844" ;
  schema:name "Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)"@en ;
  schema:description "A phase 2 trial of PM 8.4 mg/m^2 in diffuse large B-cell lymphoma, run by Chengdu Zenitar Biomedical Technology Co., Ltd, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05563844/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05563844> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-11-08" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:companies <https://onco.cc/companies/chengdu-zenitar-biomedical-technology/> .